[15] Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 272, 139-145
- https://doi.org/10.1016/s0076-6879(96)72017-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Chapter 31. In Vitro Approaches for the Prediction of Human Drug MetabolismPublished by Elsevier ,1994
- Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjectsPharmacogenetics, 1993
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991
- Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.British Journal of Clinical Pharmacology, 1991
- Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizersClinical Pharmacology & Therapeutics, 1990
- In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.British Journal of Clinical Pharmacology, 1988
- Tolbutamide hydroxylation by human liver microsomesBiochemical Pharmacology, 1988
- Characterisation of theophylline metabolism in human liver microsomes.British Journal of Clinical Pharmacology, 1987
- The Metabolic Fate of Tolbutamide in Man and in the RatJournal of Medicinal Chemistry, 1966